Why the study?
What is the systemic bioavailability of oral timolol in normal volunteers and uremic patients?
What is the systemic bioavailability of oral timolol in normal volunteers and uremic patients?
Timolol has a relatively high systemic bioavailability of approximately 60% after oral administration with minimal first-pass metabolism compared to other beta-blockers like propranolol.
Answers are grounded in this paper and cite their sources.
May support unchanged timolol dosing in uremia; leaves open outcome data in renal impairment.
The systemic bioavailability of timolol, a beta-adrenergic receptor blocking agent, was calculated from published data in normal volunteers and uremic patients after oral doses. Equations based on the perfusion limited model that account for the biological determinants affecting drug disposition were derived and applied to calculate systemic bioavailability. The means of the fraction of the administered oral dose reaching the systemic circulations intact drug were calculated to be 0.58 and 0.60 for normal volunteers and uremic patients, respectively. Minimal first pass biotransformation during absorption was inferred from these figures for timolol when compared with other analogs such as propranolol and alprenolol, each of which undergoes an extensive first pass effect.
No takes yet. Share an insight, caveat, or question.
Ragab El‐Rashidy (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: